Journal profile · Medicine-Infectious Diseases
JACAntimicrobial Resistance
ISSN 2632-1823 · Oxford University Press · United Kingdom
JACAntimicrobial Resistance: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 5.3 (journal website); fully open access; APC charged, amount not published; median 97 days to acceptance (67 articles, last 24 months); 462 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
JACAntimicrobial Resistance is published by Oxford University Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria and Antibiotics Pharmacokinetics and Efficacy, together about 49% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JAC-Antimicrobial Resistance (JAC-AMR) is a fully open access Society journal from the British Society for Antimicrobial Chemotherapy (BSAC). As one of the most important threats to global health, antimicrobial resistance requires an innovative, interdisciplinary response. The mission of JAC-AMR is to disseminate cutting-edge research, and provide education regarding the origins, spread, characteristics, diagnosis, treatment, and prevention of multi-drug resistant organisms that result in difficult-to treat infections around the world. We publish original research articles, reviews, clinically oriented opinions and viewpoints, debates, brief reports, and reviews of educational resources. JAC-AMR focuses on advancing the science and knowledge of antimicrobial resistance, stewardship and use relating to antibacterial, antifungal, antiviral and antiprotozoal agents. The Journal recognizes the importance of the “One Health” framework to understand AMR, and encourages AMR investigations that cover the spectrum of environment, animal and human health. JAC-AMR is dedicated to the dissemination of research on antimicrobial stewardship practices, and encourages the use of rigorous non-quantitative methodology where appropriate. Publishing with JAC-Antimicrobial Resistance As a JAC-AMR author, you support the British Society for Antimicrobial Chemotherapy (BSAC) and join a rich community dedicated to saving lives by fighting infection. BSAC members are eligible for a reduced APC, and APCs are waived for authors in developing countries and regions. JAC-AMR authors, reviewers, and editors are part of a forward-thinking, innovative community with a focus on scientific excellence and interdisciplinary approaches to advancing our field. Discover the latest journal metrics (including readership, category rankings, and article processing times) in the below table. A global audience for your work JAC-AMR connects powerful ideas with the widest audience to give your research the greatest possible impact. Strong annual readership from around the globe An impressive CiteScore (Scopus) and a strong Impact Factor (Clarivate) Indexed in PubMed, Web of Science, and Scopus, making content easily discoverable. View our full list of indexing services at the bottom of this page. 96% of JAC articles mentioned online*, via news outlets, policy documents, clinical guidelines, and social media. Research has appeared in news outlets and policy documents from sources including The Independe
From the journal's Aims & Scope
Research area (LetPub): Medicine-Infectious Diseases
Editor-in-chief David van Duin.Publisher website
Editorial board by country: 2 in mainland China (about 2%); most named United States 35, United Kingdom 23, South Africa 8, India 7, Australia 5 (120 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Use and ResistanceImmunology and Microbiology24.3%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology15.3%
- Antibiotics Pharmacokinetics and EfficacyMedicine9.4%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology7.1%
- Urinary Tract Infections ManagementMedicine6.2%
- Nosocomial Infections in ICUMedicine4.7%
- Antimicrobial Resistance in StaphylococcusMedicine4.5%
- Pharmaceutical and Antibiotic Environmental ImpactsEnvironmental Science3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Microbiology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
| Minor | Microbiology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ESCIWeb of SciencePMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 5.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.4Publisher website ·
- CiteScore 2026-06
- 5.3LetPub ·
- CiteScore (publisher) 2025
- 5.3Publisher website ·
- SJR 2026-06
- 1.06LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 48OpenAlex ·
- i10-index
- 374OpenAlex ·
- 2-year mean citedness
- 2.51OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher) 2025
- 500,522Publisher website ·
Articles by year OpenAlex count · 2,022 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 349 | 349 | 63 |
| 2025 | 462 | 462 | 960 |
| 2024 | 290 | 290 | 1,738 |
| 2023 | 271 | 271 | 1,867 |
| 2022 | 231 | 231 | 2,684 |
| 2021 | 208 | 208 | 3,834 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
97 daysMedian, submission to acceptance · P25–P75 72 days – 130 days
- Acceptance to online
- median 21 days (67 articles)
- Submission to online
- median 115 days
- Sample
- 67 articles with submission and acceptance dates (536 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- Submission to first decision 2025
- 24 daysPublisher website ·
- Submission to final decision 2025
- 43 daysPublisher website ·
- Acceptance to publication
- 23.5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 1,883 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | GBP 1,978 | — | — | |
| LetPub | GBP 1,883 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Page charges
- USD 3,625
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 3,500 words
- Cover letter
- Required
- Not considered
- claims of priority in article titles
Article types accepted9, with length limits
- brief reportAll documents should be double spaced, and the margins should not be excessively wide. A clear, legible single font (which is readily available internationally)…main text ≤ 1,500 words · references ≤ 20
- brief reportsBrief reports These should have the same format as OriginalLength not stated
- correspondenceLetters on topics of concern or interest in the field of antimicrobial chemotherapy, particularly arising from papers or letters already published in the Journa…main text ≤ 800 words · references ≤ 10
- original articleAll documents should be double spaced, and the margins should not be excessively wide. A clear, legible single font (which is readily available internationally)…main text ≤ 3,500 words
- original researchAll documents should be double spaced, and the margins should not be excessively wide. A clear, legible single font (which is readily available internationally)…Length not stated
- review articleThere is no length limit for this format. These generally aim to give an overview of a field suitable for a wide audience, and they should include a synopsis (2…main text ≤ 250 words
- review articlesThere is no length limit for this format. These generally aim to give an overview of a field suitable for a wide audience, and they should include a synopsis (2…Length not stated
- viewpointAll documents should be double spaced, and the margins should not be excessively wide. A clear, legible single font (which is readily available internationally)…main text ≤ 1,000 words
- viewpoint and review articlesViewpoint and review articles: will usually be solicited by one of the Editors unsolicited viewpoint or review articles will be considered only after prior disc…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints, Self-archiving
- Authorship Authorship
The authorship of the paper should be confined to those who have made a significant contribution to the design and execution of the work described. In the case of clinical trials/randomized control trials it is compulsory for the contribution of each author to be clearly stated in the Transparency declarations section, after the information on conflicts of interest. Authors of other types of artic…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
Conflicts of interest have the potential to affect authors, referees and Editors (including Senior Editors and the Editor-in-Chief). JAC-AMR has the following systems in place to deal with conflicts of interest: Authors. Authors are required to include a Transparency declarations section in every submission to the Journal (for details see below). Referees. When invited to act, and again when they …
Source ↗Publisher website ·- Data availability Availability of Data and Materials
Where ethically feasible, JAC-AMR strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. For information on general repositories for all data types, and a list of recommended reposito…
Source ↗Publisher website ·- Publication ethics Misconduct
We will energetically pursue accusations of misconduct directed at authors, Editors or referees and have a number of sanctions at our disposal including the option to inform employers about accusations and ask them to mount their own internal investigations. Accusations should not be made lightly or in the absence of the likelihood of supporting evidence being obtainable. The Journal may take the …
Source ↗Publisher website ·- License & copyright Copyright
Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online copyright licence to publish form. Papers funded by the Wellcome Trust or RCUK will be given the option to select the Creative Commons Attribution licence (CC-BY) in compliance with their open access policies. Please note that by submitting an article for publication you confirm that you are the c…
Source ↗Publisher website ·- Open access Third-party content in Open Access papers
If your article contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material: Title of content Author, Original publication, year of original publication, by permission of [rights holder] This image/content is not covered by the terms of the Creative Commons licence of this publication. For permi…
Source ↗Publisher website ·- Peer review Peer review
Single-blind peer review Model summary
JAC-AMR follows single-blind peer review. After preliminary examination of the submission by Editorial Office staff to check that all the necessary elements are present, the manuscript is passed to the Editor-in-Chief. The Editor-in-Chief then assigns the manuscript to an appropriate Senior Editor. The Senior Editor is then responsible for selecting an Editor to handle the manuscript. Manuscripts …
Source ↗Publisher website ·- Preprints Preprint Policy
Authors retain the right to make an Author’s Original Version (preprint) available through various channels, and this does not prevent submission to the journal. For further information see our Online Licensing, Copyright and Permissions policies. If accepted, the authors are required to update the status of any preprint, including your published paper’s DOI, as described on our Author Self-Archiv…
Source ↗Publisher website ·- Self-archiving
Author Self-Archiving Policy Model summary
For information about JAC-AMR's policy, please visit our Author Self-Archiving Policy Page.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2632-1823
- Latest issue on the website
- Volume 8, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JACAntimicrobial Resistance
What CAS zone is JACAntimicrobial Resistance in?
In the 2025 upgraded edition of the CAS Journal Ranking, JACAntimicrobial Resistance is in Zone 4 of Medicine, and in Zone 3 of the minor category Microbiology / Pharmacology & Pharmacy / Infectious Diseases. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JACAntimicrobial Resistance?
The journal's website gives an impact factor of 5.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.3, h-index 48.
How long does peer review take at JACAntimicrobial Resistance?
Based on the dates recorded on 67 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 97 days (interquartile range 72–130 days); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JACAntimicrobial Resistance?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 3,500 words; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of JACAntimicrobial Resistance based?
Of the 120 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United States (35), United Kingdom (23) and South Africa (8). Counted from the institutions listed on the board page; for reference only.
Which databases index JACAntimicrobial Resistance?
According to LetPub and DOAJ records, JACAntimicrobial Resistance is indexed in Scopus and DOAJ. The journal's website also lists ESCI, Web of Science and PMC; that list has not been checked against each database.
Is JACAntimicrobial Resistance open access, and what is the APC?
JACAntimicrobial Resistance is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .